July 2013 FDA Recall Drug by Vistapharm, Inc.
D-913-2013 - Failed Impurites/Degradation Specifications
This Class II drug recall was voluntarily initiated by Vistapharm, Inc. on July 4, 2013 for the product Drug. The FDA reported the reason for recall as failed impurites/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-913-2013
Failed Impurites/Degradation Specifications: Test failure of single largest peak at 18 months.
07-04-2013
08-28-2013
1,707,050 cups / 5ml ea.
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
VistaPharm, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide.
08-04-2014
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Nystatin Oral Suspension, USP 500,000 units/ 5 mL (NDC 66689-037-01 ) Rx Only, Manufactured by VistaPharm, Inc. Largo, FL 33771
Batch or Lot Expiration Information
Lot# 240200, 243000, 244800, 245600, 250800 and 253600. Exp 06/13.